# Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

> **NCT04254419** · PHASE1 · RECRUITING · sponsor: **Nationwide Children's Hospital** · enrollment: 18 (estimated)

## Conditions studied

- High Grade Glioma

## Interventions

- **BIOLOGICAL:** NK cells

## Key facts

- **NCT ID:** NCT04254419
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-04
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-10
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04254419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04254419, "Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04254419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*